Volume 28, Supplement—December 2022
SUPPLEMENT ISSUE
Workforce
Use of Project ECHO in Response to COVID-19 in Countries Supported by US President’s Emergency Plan for AIDS Relief
Janell Wright
, Laura Tison, Helen Chun, Cristine Gutierrez, Mariangeli Freitas Ning, Rosa Elena Morales, Beatriz Lopez, James Simpungwe, Kenneth Masamaro, Nazira Usmanova, Gram Mutandi, Sudhir Bunga, and Simon Agolory
, Laura Tison, Helen Chun, Cristine Gutierrez, Mariangeli Freitas Ning, Rosa Elena Morales, Beatriz Lopez, James Simpungwe, Kenneth Masamaro, Nazira Usmanova, Gram Mutandi, Sudhir Bunga, and Simon Agolory
Table 1
Characteristics of projects Incorporating COVID-19 topics in HIV/TB Project ECHO programs*
| Project ECHO characteristics | Coordinating organizations | COVID-19 topics covered during ECHO sessions | Main COVID-19 topics |
|---|---|---|---|
| South Sudan HIV ECHO: first session Mar 11, 2020, and occurred weekly; range 219–322 participants. |
ICAP South Sudan, College of Physicians and Surgeons of South Sudan, Juba Teaching Hospital (Central Equatoria State) |
1) Introduction to COVID-19; 2) protecting frontline healthcare workers to ensure continuity of services; 3) case management 1: mild/moderate and severe cases; 4) case management 2: critical cases and special populations; 5) infection prevention and control; 6) patient screening, triage, isolation, and contact tracing; 7) rational use of PPE; 8) cleaning and waste/dead body management |
1) Case management 1: mild/ moderate and severe cases; 2) case management 2: critical cases and special populations; 3) infection prevention and control |
| Namibia ECHO: first session Mar 17, 2020, and occurred weekly; range 172–390 participants |
Namibia Ministry of Health and Social Services |
1) COVID-19 and patients on ART; 2) HIV patient management in the COVID-19 context; 3) overview of infection prevention and control measures in COVID-19 pandemic; 4) national update on COVID-19 developments; 5) pediatric HIV disclosure in the context of COVID-19; 6) how to prepare ART clinics for COVID-19 |
1) Case management 1: basics of COVID-19, management of mild/moderate and severe cases 2) case management 2: advanced management of critical cases and special populations; 3) infection prevention and control; 4) Introduction and planning for IPC: WHO Tabletop Exercise |
| Zambia Project ECHO TB/HIV: first session Jan 29, 2020, and occurred weekly with ad hoc sessions; range 64–65 participants |
Zambia Ministry of Health |
1) Clinical update on the Novel Coronavirus (2019-nCoV); 2) COVID-19 orientation for HCWs; 3) COVID-19 pandemic response; 4) COVID-19 in children; 5) PPE donning and doffing; 6) clinical features of COVID-19; 7) COVID-19 pandemic literature review; 8) psychological aspects of the COVID-19 pandemic; 9) COVID-19 management – experiences from China and Italy; 10) COVID-19 and management of noncommunicable diseases and comorbidities; 11) ensuring quality HIV services during COVID-19 pandemic; 12) COVID-19 in Zambia: “What We Should Know”; 13) TB/TPT guidance during the COVID-19 pandemic; 14) COVID-19 vaccine |
1) Sustaining quality HIV services amidst COVID-19; 2) clinical features of COVID-19; 3) COVID-19 vaccination |
| Kyrgyzstan HIV ECHO Project: first session Sep 23, 2016, and occurred biweekly and weekly; range 30–60 participants. |
Kyrgyz State Medical Institute for Postgraduate Education |
Introduction to COVID-19 |
1) Outpatient COVID-19 management; 2) COVID-19 diagnosis, clinical features, and management; 3) etiology, clinical features; 4) diagnostics and treatment |
| Central America HIV Treatment ECHO: first session Oct 9, 2020, and occurred weekly; range 31–87 participants. | SE-COMISCA El Salvador | COVID-19 and HIV co-infection | COVID-19 and HIV co-infection |
*ART, antiretroviral therapy; ECHO, Extension for Community Healthcare Outcomes; IPC, infection prevention and control; PPE, personal protective equipment; SE-COMISCA, Secretaría Ejecutiva del Consejo de Ministros de Salud de Centroamérica y República Dominicana; TB, tuberculosis; TPT, tuberculosis preventive treatment; WHO, World Health Organization.
Page created: October 15, 2022
Page updated: December 11, 2022
Page reviewed: December 11, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.